Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000161137 | SCV003247349 | uncertain significance | Congenital myasthenic syndrome 15 | 2022-08-08 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. ClinVar contains an entry for this variant (Variation ID: 183014). This premature translational stop signal has been observed in individual(s) with clinical features ALG14-related conditions (PMID: 23404334). It has also been observed to segregate with disease in related individuals. This variant is present in population databases (rs367570129, gnomAD 0.008%). This sequence change creates a premature translational stop signal (p.Arg104*) in the ALG14 gene. It is expected to result in an absent or disrupted protein product. However, the current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in ALG14 cause disease. |
Gene |
RCV003221829 | SCV003918678 | pathogenic | not provided | 2022-10-14 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25305004, 25159927, 23404334, 34908252) |
OMIM | RCV000161137 | SCV000211855 | pathogenic | Congenital myasthenic syndrome 15 | 2013-03-01 | no assertion criteria provided | literature only |